Insider Transactions in Q2 2020 at Moderna, Inc. (MRNA)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
127,500
+50.0%
|
$1,530,000
$12.21 P/Share
|
|
May 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.05%
|
$315,000
$63.94 P/Share
|
|
May 12
2020
|
Elizabeth G Nabel Director |
SELL
Open market or private sale
|
Direct |
30,000
-67.65%
|
$1,980,000
$66.0 P/Share
|
|
May 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125,044
-39.43%
|
$8,127,860
$65.01 P/Share
|
|
May 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,044
+50.0%
|
$1,500,528
$12.21 P/Share
|
|
May 12
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-2.92%
|
$15,665,000
$65.0 P/Share
|
|
May 12
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+7.24%
|
$2,651,000
$11.56 P/Share
|
|
May 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.05%
|
$320,000
$64.83 P/Share
|
|
May 12
2020
|
Stephane Bancel Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
55,568
+0.82%
|
-
|
|
May 11
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
12,281,179
-48.84%
|
-
|
|
May 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,127
-0.06%
|
$597,493
$59.57 P/Share
|
|
May 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,376
-0.05%
|
$199,184
$59.57 P/Share
|
|
May 08
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.26%
|
$618,576
$56.11 P/Share
|
|
May 05
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,770
-100.0%
|
$238,500
$50.48 P/Share
|
|
May 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
24,093
-0.64%
|
$1,156,464
$48.7 P/Share
|
|
May 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,349
-0.07%
|
$208,752
$48.7 P/Share
|
|
May 01
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
25,000
-58.29%
|
$1,200,000
$48.32 P/Share
|
|
May 01
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$300,000
$12.21 P/Share
|
|
Apr 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.72%
|
$519,162
$47.15 P/Share
|
|
Apr 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-67.7%
|
$470,000
$47.15 P/Share
|
|
Apr 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$245,000
$49.12 P/Share
|
|
Apr 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.06%
|
$245,000
$49.1 P/Share
|
|
Apr 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,807
-0.08%
|
$576,315
$45.0 P/Share
|
|
Apr 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,269
-0.06%
|
$192,105
$45.0 P/Share
|
|
Apr 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.34%
|
$508,116
$46.3 P/Share
|
|
Apr 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.37%
|
$480,000
$48.81 P/Share
|
|
Apr 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,936
-0.04%
|
-
|
|
Apr 15
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.32%
|
$720,000
$36.5 P/Share
|
|
Apr 15
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
23,403
-55.59%
|
$842,508
$36.91 P/Share
|
|
Apr 15
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,403
+50.0%
|
$280,836
$12.21 P/Share
|
|
Apr 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,462
-0.59%
|
$654,784
$32.0 P/Share
|
|
Apr 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,139
-0.05%
|
$100,448
$32.0 P/Share
|
|
Apr 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.25%
|
$320,000
$32.62 P/Share
|
|
Apr 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-28.76%
|
$320,000
$32.0 P/Share
|
|
Apr 06
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
300
-100.0%
|
$10,500
$35.13 P/Share
|
|
Apr 06
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+50.0%
|
$3,600
$12.21 P/Share
|
|
Apr 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.64%
|
$353,472
$32.81 P/Share
|
|
Apr 03
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
13,697
-100.0%
|
$479,395
$35.09 P/Share
|
|
Apr 03
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,697
+50.0%
|
$164,364
$12.21 P/Share
|
|
Apr 03
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-22.34%
|
$320,000
$32.81 P/Share
|
|
Apr 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,017
-0.06%
|
$300,510
$30.05 P/Share
|
|
Apr 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,339
-0.05%
|
$100,170
$30.05 P/Share
|